← 治験一覧に戻る
虚血性心筋症に対するヒト(同種)iPS細胞由来心筋細胞シートの臨床試験
基本情報
- NCT ID
- NCT04696328
- ステータス
- 不明
- 試験のフェーズ
- 第1相
- 試験タイプ
- 介入
- 目標被験者数
- 10
- 治験依頼者名
- Osaka University
概要
Targeting patients with severe ischemic cardiomyopathy, the purpose of this study is as follows: to confirm short-term efficacy by observing changes and transitions in cardiac function and clinical symptoms compared with each patient's baseline (before and after comparison) by human iPS cell-derived cardiomyocyte sheet transplantation, and to evaluate the safety and tolerability including the combined use of immunosuppressants.
対象疾患
Myocardial Ischemia
介入
Human (allogeneic) iPS cell derived-cardiomyocyte sheet(BIOLOGICAL)
依頼者(Sponsor)
Osaka University(OTHER)
Cuorips(UNKNOWN)
実施施設 (1)
大阪大学医学部附属病院
Suita, Osaka, Japan(RECRUITING)